# CONVERGE - Epi/Endo Ablation For Treatment of Persistent Atrial Fibrillation(AF)

> **NCT01984346** · NA · COMPLETED · sponsor: **AtriCure, Inc.** · enrollment: 170 (actual)

## Conditions studied

- Persistent Atrial Fibrillation

## Interventions

- **DEVICE:** AtriCure EPi-Sense-AF Guided Coagulation System with VisiTrax
- **DEVICE:** Endocardial RF Catheter ablation using Open Irrigated-tip RF Abaltion Catheter with unidirectional or bidirectional steering

## Key facts

- **NCT ID:** NCT01984346
- **Lead sponsor:** AtriCure, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-12
- **Primary completion:** 2019-08
- **Final completion:** 2023-10
- **Target enrollment:** 170 (ACTUAL)
- **Last updated:** 2023-11-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01984346

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01984346, "CONVERGE - Epi/Endo Ablation For Treatment of Persistent Atrial Fibrillation(AF)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01984346. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*